Induction of endothelial cell damage by hCMV molecular mimicry

Trends in Immunology

Volumn 26, Issue 1, 2005, Pages 19-24

  Lunardi, Claudio ^a   Bason, Caterina ^b   Corrocher, Roberto ^a   Puccetti, Antonio ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CELL DAMAGE; CELL SURFACE; ENDOTHELIUM CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; METABOLISM; MOLECULAR MIMICRY; MOLECULE; PATHOGENESIS; REVIEW; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

EID: 11144241470     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.10.009     Document Type: Article

References (50)

1. F. Di Rosa, and V. Barnaba Persisting viruses and chronic inflammation: understanding their relation to autoimmunity Immunol. Rev. 164 1998 17 27
2. Z.S. Zhao Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection Science 279 1998 1344 1347
3. C. Wim Ang The Guillain-Barré syndrome: a true case of molecular mimicry Trends Immunol. 25 2004 61 66
4. C. Benoist, and D. Mathis Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2 2001 797 801
5. J.P. Pandey, and E.C. LeRoy Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection and coronary restenosis Arthritis Rheum. 41 1998 10 15
6. M.J. Reddehase Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance Nat. Rev. Immunol. 2 2002 831 844
7. A. Alcami Viral mimicry of cytokines, chemokines and their receptors Nat. Rev. Immunol. 3 2003 36 50
8. M. Jarvis, and J. Nelson Human cytomegalovirus persistence and latency in endothelial cells and macrophages Curr. Opin. Microbiol. 5 2002 403 407
9. G. Wick Atherosclerosis as an autoimmune disease: an update Trends Immunol. 22 2001 665 669
10. D.C. Haynes, and M.E. Gershwin The immunopathology of progressive systemic sclerosis (PSS) Semin. Arthritis Rheum. 11 1982 331 351
11. G.R. Harvey, and N.J. McHugh Serologic abnormalities in systemic sclerosis Curr. Opin. Rheumatol. 11 1999 495 502
12. R. Sgonc Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma J. Clin. Invest. 98 1996 785 792
13. A. Bordron The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis J. Clin. Invest. 101 1998 2029 2035
14. M. Worda In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay Arthritis Rheum. 48 2003 2605 2614
15. R. Sgonc Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95 Arthritis Rheum. 43 2000 2550 2562
16. M. Neidhart Increased serum levels of antibodies against cytomegalovirus and prevalence of autoantibodies in systemic sclerosis Arthritis Rheum. 42 1999 389 392
17. T. Muryoi Antitopoisomerase I monoclonal antibodies from scleroderma patients and tight skin mouse interact with similar epitopes J. Exp. Med. 175 1992 1103 1109
18. K. Larsson Reduced risk for extensive chronic graft-versus-host-disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus Transplantation 77 2004 526 531
19. Y. Zhang Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines and immune cell activation J. Immunol. 168 2002 3088 3098
20. M.C. Ruzek A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease Arthritis Rheum. 50 2004 1319 1331
21. C. Lunardi Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells Nat. Med. 6 2000 1183 1186
22. J.M. Tarrant Tetraspanins: molecular organizers of the leukocyte surface Trends Immunol. 24 2003 610 617
23. C.J. Murray, and A.D. Lopez Global mortality, disability, and the contribution of risk factors: global burden of disease study Lancet 349 1997 1436 1442
24. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
25. G. Wick Autoimmune and inflammatory mechanisms in atherosclerosis Annu. Rev. Immunol. 22 2004 361 403
26. D.R. Greaves, and K.M. Channon Inflammation and immune responses in atherosclerosis Trends Immunol. 23 2002 535 541
27. M. Leinonen, and P. Saikku Evidence for infectious agents in cardiovascular disease and atherosclerosis Lancet Infect. Dis. 2 2002 11 17
28. J. Zhu Antibodies to HSP60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis Circulation 103 2001 1071 1075
29. J.B. Muhlestein Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease Circulation 102 2000 1917 1923
30. J. Zhu Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease Circulation 102 2000 2491 2496
31. S. Blankenberg Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease Circulation 103 2001 2915 2921
32. R. Horvath The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis J. Clin. Virol. 16 2000 17 24
33. A. Blum Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis Clin. Exp. Med. 3 2003 157 160
34. C. Grahame-Clarke Human cytomegalovirus seropositivity is associated with impaired vascular function Circulation 108 2003 678 683
35. N.V. Sambiase CMV and transplant related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study Mod. Pathol. 13 2000 173 179
36. S. Fateh-Moghadam Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy Transplantation 76 2003 1470 1474
37. J.L. Melnick Cytomegalovirus DNA in arterial walls of patients with atherosclerosis J. Med. Virol. 42 1994 170 174
38. M.S. Burnett Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes Circulation 109 2004 893 897
39. C. Bason Interaction of antibodies against cytomegalovirus with heat shock protein 60 in pathogenesis of atherosclerosis Lancet 362 2003 1971 1977
40. D.N. Streblow The HCMV chemokine receptor US28 is a potential target in vascular disease Curr. Drug Targets Infect. Disord. 1 2001 151 158
41. G. Borland, and W. Cushley Positioning the immune system: unexpected roles for α6-integrins Immunology 111 2004 381 383
42. G.A. Stouffer, and S.S. Smyth Effects of thrombin on interactions between β3-integrins and extracellular matrix in platelets and vascular cells Arterioscler. Thromb. Vasc. Biol. 23 2003 1971 1978
43. O.S. Mahdi Serum immunoglobulin G antibodies to chlamydial HSP60 but not to human and bacterial homologs are associated with coronary artery disease Circulation 106 2002 1659 1663
44. A.G. Pockley Heat shock proteins as regulators of the immune response Lancet 362 2003 469 476
45. B. Kilmartin, and D.J. Reen HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli Eur. J. Immunol. 34 2004 2041 2051
46. Y. Takahashi Human parvovirus B19 in rheumatoid arthritis Int. Rev. Immunol. 17 1998 309 321
47. + T cells found within joints of patients with inflammatory arthritis Arthritis Rheum. 44 2001 2038 2045
48. N.R. Rose, and I.R. Mackay Molecular mimicry: a critical look at exemplary instances in human diseases Cell. Mol. Life Sci. 57 2000 542 551
49. D. Hamamdzic The role of infectious agents in the pathogenesis of systemic sclerosis Curr. Opin. Rheumatol. 14 2002 694 698
50. A. Tedgui, and Z. Mallat Apoptosis as a determinant of atherothrombosis Thromb. Haemost. 86 2001 420 426